ZA939428B - Therapeutic for gram-positive diseases of aquatic species - Google Patents

Therapeutic for gram-positive diseases of aquatic species

Info

Publication number
ZA939428B
ZA939428B ZA939428A ZA939428A ZA939428B ZA 939428 B ZA939428 B ZA 939428B ZA 939428 A ZA939428 A ZA 939428A ZA 939428 A ZA939428 A ZA 939428A ZA 939428 B ZA939428 B ZA 939428B
Authority
ZA
South Africa
Prior art keywords
gram
therapeutic
aquatic species
positive diseases
diseases
Prior art date
Application number
ZA939428A
Other languages
English (en)
Inventor
Earl Eugene Ose
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA939428B publication Critical patent/ZA939428B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Fodder In General (AREA)
  • Feed For Specific Animals (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA939428A 1992-12-21 1993-12-15 Therapeutic for gram-positive diseases of aquatic species ZA939428B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99457992A 1992-12-21 1992-12-21

Publications (1)

Publication Number Publication Date
ZA939428B true ZA939428B (en) 1995-06-15

Family

ID=25540817

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA939428A ZA939428B (en) 1992-12-21 1993-12-15 Therapeutic for gram-positive diseases of aquatic species

Country Status (12)

Country Link
EP (1) EP0606747A1 (fr)
JP (1) JPH06217708A (fr)
KR (1) KR940013500A (fr)
CN (1) CN1093371A (fr)
AU (1) AU5252793A (fr)
CA (1) CA2111635A1 (fr)
CZ (1) CZ276893A3 (fr)
HU (1) HUT66447A (fr)
IL (1) IL108047A0 (fr)
NO (2) NO934655L (fr)
NZ (1) NZ250465A (fr)
ZA (1) ZA939428B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6605599B1 (en) 1997-07-08 2003-08-12 Bristol-Myers Squibb Company Epothilone derivatives
US6608033B1 (en) 1999-08-27 2003-08-19 Pfizer Inc. Treatment or prevention of coccidiosis
US6518252B2 (en) * 2000-09-20 2003-02-11 University Of Georgia Research Foundation, Inc. Method of treating aquatic animals with an antimicrobial agent and chelating agent
EP1446103B1 (fr) * 2001-10-19 2015-12-23 Idexx Laboratories, Inc. Compositions injectables permettant une administration controlee d'un compose pharmacologiquement actif
PT2782922T (pt) 2011-11-25 2018-02-05 The Kitasato Inst Derivados antibacterianos de tilosina e processos para a sua preparação
AU2014270353B2 (en) 2013-05-23 2018-09-20 Elanco Animal Health Gmbh Tylosin derivatives and method for preparation thereof
CN105456184B (zh) * 2015-12-11 2019-04-16 天津市中升挑战生物科技有限公司 一种替米考星注射液及其制备方法及应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820695A (en) * 1982-09-13 1989-04-11 Eli Lilly And Company C-20-dihydro-deoxy-(cyclic amino)-derivatives of macrolide antibiotics

Also Published As

Publication number Publication date
NO934655L (no) 1994-06-22
CN1093371A (zh) 1994-10-12
HUT66447A (en) 1994-11-28
KR940013500A (ko) 1994-07-15
NO934655D0 (no) 1993-12-16
IL108047A0 (en) 1994-04-12
NZ250465A (en) 1995-10-26
EP0606747A1 (fr) 1994-07-20
CA2111635A1 (fr) 1994-06-22
CZ276893A3 (en) 1994-07-13
AU5252793A (en) 1994-06-30
JPH06217708A (ja) 1994-08-09

Similar Documents

Publication Publication Date Title
AU2845492A (en) Dipyridamole for the treatment of proliferative diseases
EP0799617A3 (fr) Agent thérapeutique pour le traitement des maladies neurologiques
HU9300536D0 (en) Compounds of medical effect
AU8910891A (en) Treatment of lung diseases
AP9200428A0 (en) Compounds for treating leukotriene-related diseases
ZA939428B (en) Therapeutic for gram-positive diseases of aquatic species
ZA914322B (en) Pyridyl-benzoic acid derivatives for treating leukotrienerelated diseases
GB2216412B (en) Interleukin-6 molecule for the treatment of bone-related diseases
IL104132A0 (en) Compositions for the treatment of mammalian diseases
EP0457671A3 (en) Dipyridamide for the treatment of diseases of the central or peripheral nervous system
ZA935647B (en) Treatment of sickle cell disease
IL101749A0 (en) Treatment of mastitis
AU5018893A (en) Substituted hydrindanes for the treatment of angiogenesis-dependent diseases
AU651305B3 (en) Therapeutical animal spa
ZA936136B (en) Treatment of skin diseases
GB2266241B (en) Treatment of pastures
AU7715291A (en) Treatment of horses using ethylestrenol
GB9025154D0 (en) Treatment of lung diseases
GB9012960D0 (en) New use of macrolide compounds for nervous diseases
GB9207616D0 (en) Treatment of animal slurries
GB9012954D0 (en) New use of macrolide compounds for skin diseases
GB9126079D0 (en) The treatment of inflammatory diseases
ZA932456B (en) Control of tuber diseases
GB9210477D0 (en) Treatment of hay
GB9226526D0 (en) Therapeutic compounds